Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg

A new formulation of injectable aripiprazole for administration every 2 months showed similar rates of treatment-emergent adverse events to aripiprazole once-monthly 400 mg. Patients in both groups remained clinically stable throughout the 32-week period.